Skip to main content
. 2011 May 3;2(3):e00066-11. doi: 10.1128/mBio.00066-11

TABLE 2 .

Prevalence of virulence-associated genes among E. coli isolates from different clinical settings

Isolate type % of isolates with genea
Adhesins
Toxins
Outer membrane iron receptors
fimA papA hlyA cnf1 tosA sat pic tsh chuA hma iutA iroN fyuA iha ireA
Fecal 98.9 26.4 13.2 7.7 11.0 19.8 12.1 20.9 39.6 26.4 31.9 20.9 47.3 31.9 14.3
CHb 97.6 51.2 19.5 4.9 19.5 41.5 12.2 48.8 75.6 34.1 58.5 26.8 78.0 46.3 24.4
ABUc 98.5 54.4 35.3 33.8 26.5 33.8 23.5 63.2 73.5 51.5 45.6 41.2 83.8 35.3 16.2
Cystitis 97.3 67.6 48.6 32.4 16.2 32.4 18.9 54.1 83.8 81.1 43.2 48.6 89.2 37.8 10.8
Pyelonephritis 98.7 63.6 48.1 13.0 28.6 51.9 29.9 67.5 89.6 61.0 66.2 41.6 93.5 55.8 27.3
tosA -positive strains 98.4 59.4 70.3 37.5 100.0 67.2 89.1 96.9 98.4 92.2 67.2 59.4 98.4 67.2 20.3
tosA-negative strains 98.4 47.2 21.6 12.0 0.0 26.8 2.0 36.8 61.6 36.4 43.2 28.0 69.6 34.4 18.4
a

 Gene prevalence is expressed as the percentage of isolates that scored on multiplex PCR.

b

 CH, compromised host anatomy.

c

 ABU, asymptomatic bacteriuria isolates.